Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T19:02:08.760Z.
Calculation as of: 2026-10-06T19:02:08.760Z.
Quote observation: 2026-10-06T18:36:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e63b0f3351cfb4e99b55b76d8265d9a833d2605075c67dfdbe278579742c9cb6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$2.68M
EV/EBIT Ratio
N/A
TTM Avg
3.47x
3Y Avg
924.04x
5Y Avg
924.04x
Market Cap
$3.00M
EV/EBIT Ratio
N/A
TTM Avg
1579.42x
3Y Avg
764.63x
5Y Avg
764.63x
Market Cap
$2.44M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intelligent Group Limited (INTJ) | $2.74M | N/A | N/A | N/A | N/A |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.72M | N/A | N/A | N/A | N/A |
| Globavend Holdings Limited (GVH)vs › | $2.68M | N/A | 3.47x | 924.04x | 924.04x |
| Top KingWin Ltd. Class A (DPU)vs › | $2.66M | N/A | N/A | N/A | N/A |
| PTL Limited (PTLE)vs › | $2.89M | N/A | N/A | N/A | N/A |
| BioNexus Gene Lab Corp. (BGLC)vs › | $3.00M | N/A | 1579.42x | 764.63x | 764.63x |
| DirectBooking Technology Co., Ltd. (ZDAI)vs › | $2.44M | N/A | N/A | N/A | N/A |
| Polar Power, Inc. (POLA)vs › | $3.17M | N/A | 43.96x | 21.31x | 40.90x |
| Iveda Solutions, Inc. (IVDA)vs › | $3.19M | N/A | N/A | N/A | N/A |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.28M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
